Related Experiment Video
Updated: May 25, 2025

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Chromatin Remodulator CHD4: A Potential Target for Cancer Interception
Krishnendu Goswami1, Karthikkumar Venkatachalam1, Surya P Singh1
1Center for Cancer Prevention and Drug Development, Stephenson Cancer Center, Hem-Onc Section, Department of Medicine, University of Oklahoma HSC, Oklahoma City, OK 73104, USA.
Chromodomain helicase DNA-binding 4 (CHD4) influences cancer development by altering gene accessibility. This chromatin remodulator is crucial for transcriptional reprogramming, impacting tumor cell proliferation and DNA damage responses.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Biology
Background:
- Cancer development involves genetic alterations and changes in gene network regulation.
- Nucleosome remodeling ATPases, like CHD4, are key in controlling gene accessibility within the nucleus.
- Chromodomain helicase DNA-binding 4 (CHD4) is an ATP-dependent chromatin remodulator involved in various cellular processes.
Purpose of the Study:
- To review and synthesize existing data on the role of CHD4 in cancer.
- To highlight CHD4's function in chromatin accessibility and transcriptional regulation in the context of cancer.
Main Methods:
- Literature review of studies investigating CHD4 in cancer.
- Analysis of CHD4's molecular domains and protein interactions.
- Examination of CHD4's involvement in cancer progression, proliferation, DNA damage response, and immune modulation.
Main Results:
- CHD4 possesses multiple domains for nucleosome mobilization and histone binding.
- CHD4 is a critical component of Nucleosome Remodeling and Deacetylase (NuRD) complexes, facilitating transcriptional reprogramming.
- Data indicate CHD4's significant role in tumor cell proliferation, DNA damage responses, and immune modulation.
Conclusions:
- CHD4-mediated chromatin accessibility is fundamental for transcriptional reprogramming.
- This reprogramming is intrinsically linked to tumor cell proliferation and overall cancer development.
- CHD4 represents a significant target for understanding and potentially treating cancer.
Related Concept Videos
Chromatin Immunoprecipitation- ChIP
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
Epigenetic Regulation
X-chromosome...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Inhibition of Cdk Activity
Abnormal Proliferation

